MedPath

Kosteneffectiviteit bepalen bij behandeling met mini-hart/longmachine bij kritisch zieke patiënte

Conditions
Heart failure, respiratory failure, extracorporeal life support, extracorporeal membrane oxygenation, intensive care, hartfalen, longfalen
Registration Number
NL-OMON25049
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
210
Inclusion Criteria

All consecutive adult patients who receive ECLS in one of the participating centers

Exclusion Criteria

< 18 years

not able to give informed consent

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health related quality of life assessed with EQ-5D-5L questionnaire 12 months after initiation of ECLS treatment
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is survival. Additional measurements are EQ-5D-VAS score and societal costs.
© Copyright 2025. All Rights Reserved by MedPath